| TROW |
Report |
Adjusted EPS |
BEAT |
pred ~$2.58 vs. cons $2.51 |
MEDIUM |
| TROW |
Report |
Net Revenue |
BEAT |
pred ~$1.96B vs. cons $1.92B |
MEDIUM |
| TROW |
Report |
Effective Fee Rate (ex. performance fees, bps) |
MISS |
pred ~37.9bps vs. cons 38.4bps |
MEDIUM |
| TROW |
Guide |
FY2026 Adjusted Operating Expense Growth (ex. carried interest) |
UNCHANGED |
guide ~3%-6% vs. cons 3%-6% (FY2026) |
HIGH |
| TROW |
Guide |
FY2026 Effective Tax Rate |
UNCHANGED |
guide ~23.5%-24.5% vs. cons 23.0%-26.0% (FY2026) |
MEDIUM |
| TROW |
Guide |
Net Client Flows / Organic Growth Commentary |
LOWER |
guide ~-1.5% organic decline vs. cons -1.0% implied (Q3 2026 trajectory) |
LOW |
| TROW |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.2% |
— |
MEDIUM |
| TROW |
Return |
5-day cumulative residual |
-2.6% (FADE) |
AUM/flows already pre-announced so the EPS/revenue beat is largely priced in after the stock's sharp run to 52-week highs (+~14% YTD); the June AUM print itself already triggered a negative reaction on outflow optics. Even with a clean EPS beat driven by market-appreciation-lifted average AUM, continued effective-fee-rate compression (mix shift to trusts/SMAs/target-date blend) implies analysts will trim out-quarter revenue/EPS estimates, and persistent active-equity mutual fund redemptions keep the organic growth debate unresolved — a 'beat but quality of beat questioned' setup that typically fades over the following days as estimate revisions catch down to the softer fee-rate/flow mix rather than the AUM beat. |
MEDIUM |